• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成含苯磺酰胺部分的新型碲化物作为具有抗肿瘤活性的碳酸酐酶抑制剂。

Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity.

机构信息

University of Florence, Department of Chemistry "Ugo Schiff", Via della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy.

NEUROFARBA Department, Section of Pharmacology and Toxicology, Università degli Studi di Firenze, Viale Pieraccini 6, 50139, Florence, Italy.

出版信息

Eur J Med Chem. 2019 Nov 1;181:111586. doi: 10.1016/j.ejmech.2019.111586. Epub 2019 Aug 5.

DOI:10.1016/j.ejmech.2019.111586
PMID:31401537
Abstract

We have synthetized a novel series of β-hydroxy tellurides bearing the benzenesulfonamide group as potent inhibitors of carbonic anhydrase enzymes. In a one pot procedure, we discovered both the ring opening reaction of the three-membered ring and the cleavage of the sulfonamide protecting moiety at the same time. Moreover, the first X-ray co-crystallographic structure of a β-hydroxy telluride derivative with hCA II is reported. The potent effects of these compounds against the tumor-associated hCA IX with low nanomolar constant inhibition values give the possibility to evaluate their activity in vitro using a breast cancer cell line (MDA-MB-231). Compounds 7e and 7g induced significant toxic effects against tumor cells after 48 h incubation in normoxic conditions killing over 50% of tumor cells at 3 μM, but their efficacy decreased in hypoxic conditions reaching the 50% of the tumor cell viability only at 30 μM. These unusual features make them interesting lead compounds to act as antitumor agents, not only as Carbonic Anhydrase IX inhibitors, but reasonably in different pathways, where hCA IX is not overexpressed.

摘要

我们合成了一系列新型的β-羟基碲化物,其中含有苯磺酰胺基团,是碳酸酐酶的有效抑制剂。在一锅法中,我们同时发现了三元环的开环反应和磺酰胺保护基的断裂。此外,还报道了首例与 hCA II 的β-羟基碲化物衍生物的 X 射线共结晶结构。这些化合物对肿瘤相关 hCA IX 的强烈抑制作用(抑制常数的纳摩尔值较低)使得有可能使用乳腺癌细胞系(MDA-MB-231)在体外评估它们的活性。在常氧条件下孵育 48 小时后,化合物 7e 和 7g 对肿瘤细胞产生了显著的毒性作用,在 3μM 时杀死了超过 50%的肿瘤细胞,但在缺氧条件下其疗效降低,仅在 30μM 时达到肿瘤细胞活力的 50%。这些不寻常的特征使它们成为有前途的抗肿瘤药物先导化合物,不仅作为碳酸酐酶 IX 抑制剂,而且在 hCA IX 未过度表达的不同途径中也具有合理的作用。

相似文献

1
Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity.合成含苯磺酰胺部分的新型碲化物作为具有抗肿瘤活性的碳酸酐酶抑制剂。
Eur J Med Chem. 2019 Nov 1;181:111586. doi: 10.1016/j.ejmech.2019.111586. Epub 2019 Aug 5.
2
Tellurides bearing benzensulfonamide as carbonic anhydrase inhibitors with potent antitumor activity.以苯磺酰胺为碳酸酐酶抑制剂的碲化物具有强大的抗肿瘤活性。
Bioorg Med Chem Lett. 2021 Aug 1;45:128147. doi: 10.1016/j.bmcl.2021.128147. Epub 2021 May 27.
3
Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.不同含磺酰胺基硫杂环支架的合成及其对碳酸酐酶 II 和 IX 的纳摩尔级抑制作用和 X 射线研究其抑制机制。
Bioorg Chem. 2018 Dec;81:642-648. doi: 10.1016/j.bioorg.2018.09.028. Epub 2018 Sep 20.
4
Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.设计和合成新型含 1,2,3-三唑的苯磺酰胺类化合物作为有效的人碳酸酐酶同工酶 I、II、IV 和 IX 抑制剂。
Eur J Med Chem. 2018 Jul 15;155:545-551. doi: 10.1016/j.ejmech.2018.06.021. Epub 2018 Jun 8.
5
Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.基于双尾芳基砜的苯磺酰胺类化合物能够与人类碳酸酐酶活性位点的疏水和亲水两部分不同匹配:用于肿瘤相关 hCA IX 同工型的选择性抑制剂。
Eur J Med Chem. 2018 May 25;152:1-9. doi: 10.1016/j.ejmech.2018.04.016. Epub 2018 Apr 10.
6
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors.哌啶基-酰肼脲基连接物在苯磺酰胺类化合物中的应用:具有高活性的碳酸酐酶 II、IX 和 XII 抑制剂的合成、体外和计算机模拟评价。
Bioorg Chem. 2020 May;98:103728. doi: 10.1016/j.bioorg.2020.103728. Epub 2020 Mar 14.
7
Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.新型 4-(4-氧代-2-芳基噻唑烷-3-基)苯磺酰胺类化合物的设计与合成:作为碳酸酐酶 IX 的选择性抑制剂,优于碳酸酐酶 I 和 II,具有潜在的抗癌活性。
Eur J Med Chem. 2013 Aug;66:372-9. doi: 10.1016/j.ejmech.2013.06.003. Epub 2013 Jun 12.
8
Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.3-氨基苯磺酰胺的吡啶鎓衍生物是肿瘤表达的碳酸酐酶同工酶 CAIX 和 CA XII 的纳摩尔级强效抑制剂。
Bioorg Chem. 2020 Oct;103:104204. doi: 10.1016/j.bioorg.2020.104204. Epub 2020 Aug 26.
9
Development of novel organometallic sulfonamides with N-ethyl or N-methyl benzenesulfonamide units as potential human carbonic anhydrase I, II, IX and XII isoforms' inhibitors: Synthesis, biological evaluation and docking studies.新型含 N-乙基或 N-甲基苯磺酰胺单元的有机金属磺酰胺作为潜在的人碳酸酐酶 I、II、IX 和 XII 同工型抑制剂的研发:合成、生物评价和对接研究。
J Inorg Biochem. 2024 Nov;260:112689. doi: 10.1016/j.jinorgbio.2024.112689. Epub 2024 Aug 4.
10
Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.新型酰基硒脲基苯磺酰胺作为碳酸酐酶I、II、VII和IX抑制剂的合成
Bioorg Med Chem. 2017 Jul 1;25(13):3567-3573. doi: 10.1016/j.bmc.2017.05.014. Epub 2017 May 9.

引用本文的文献

1
Cellular toxicity of organotellurans: a systematic review of pre-clinical studies.有机碲化物的细胞毒性:临床前研究的系统综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 16. doi: 10.1007/s00210-025-04249-x.
2
Glutathione Peroxidase-Like Activity of Functionalized Tellurides: Insights into the Oxidation Mechanism Through Activation Strain Analysis.功能化碲化物的谷胱甘肽过氧化物酶样活性:通过活化应变分析洞察氧化机制
Inorg Chem. 2025 May 26;64(20):10022-10031. doi: 10.1021/acs.inorgchem.5c00581. Epub 2025 May 9.
3
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.
抑制碳酸酐酶 IX 和 XII 的活性作为开发新型抗癌药物的候选物选择标准。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1555-1561. doi: 10.1080/14756366.2020.1801674.